DEF 14A: ClearSign Technologies Corporation Sets 2025 Annual Meeting Amidst Contested Director Nominations and Governance Shifts

ClearSign Technologies Corporation has scheduled its 2025 Annual Meeting of Stockholders for July 25, 2025, to vote on director elections, auditor appointment, and executive compensation, while actively addressing an invalid director nomination attempt by Jeffrey Feinglas.

Summary

• The 2025 Annual Meeting of Stockholders will be held virtually on July 25, 2025, at 1:00 p.m. Central Daylight Standard Time.
• Stockholders will vote on three key proposals: (1) the election of six members to the board of directors, (2) the advisory approval of BPM CPA LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and (3) the advisory approval of the compensation paid to named executive officers.
• Jeffrey Feinglas submitted a notice to nominate two director candidates, but the Company has deemed this 'Purported Feinglas Notice' invalid due to material omissions and deficiencies in compliance with its Bylaws.
• The Company urges stockholders to vote only on the Board's proposed director nominees using the WHITE proxy card and to disregard any materials sent by or on behalf of Mr. Feinglas.
• If litigation occurs and a court determines Mr. Feinglas's notice is valid, the Company would amend the proxy statement, issue a universal proxy card, and potentially delay the Annual Meeting.
• The Board unanimously recommends voting FOR all proposed director nominees: Judith S. Schrecker, Catharine M. de Lacy, G. Todd Silva, Colin James Deller, Anthony DiGiandomenico, and Louis J. Basenese.
• The Board also unanimously recommends voting FOR the approval of BPM CPA LLP and FOR the advisory approval of named executive officer compensation.
• As of May 29, 2025, there were 52,422,532 shares of common stock outstanding.
• Current directors and executive officers beneficially owned approximately 4.96% of the Company's common stock outstanding as of May 29, 2025.
• Otter Capital LLC beneficially owned 19.99% of common stock, comprising 8,434,774 shares and 2,557,000 shares issuable upon warrant exercise.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it outlines standard corporate governance procedures and board recommendations, the significant focus on a contested director nomination and the explicit urging to disregard an activist shareholder's materials introduce a notable negative undertone and suggest internal conflict. The high legal costs associated with proxy solicitation also contribute to a less positive outlook, despite the resolution of other shareholder disputes.

Positives

• The Board successfully entered into Cooperation Agreements with Anthony DiGiandomenico and Richard Clarkson, resolving previous nomination attempts from these parties and leading to the appointment of Messrs. DiGiandomenico and Louis J. Basenese to the Board.
• The company maintains robust corporate governance frameworks, including a Code of Business Conduct and Ethics, an Insider Trading Policy, and a newly adopted Compensation Recovery Policy (Clawback Policy) to comply with Nasdaq rules.
• The Audit Committee actively oversees risks related to cybersecurity, indicating a proactive approach to managing digital threats.
• Non-executive directors' annual compensation is paid in restricted stock units, which is designed to build an ownership stake and align their interests with those of the Company's stockholders.

Negatives

• The Company is engaged in a contentious shareholder dispute with Jeffrey Feinglas, whose director nomination notice has been declared invalid by the Board, leading to a strong recommendation for shareholders to disregard his materials.
• Significant costs have been incurred for proxy solicitation, with an estimated total of $845,000, including $750,000 in legal fees for the Special Committee established to manage shareholder nominations.
• Two Section 16(a) reports for Dr. Deller (CEO) and Mr. Hinds (CFO) were inadvertently filed late, related to bonus grants and tax withholding dispositions, indicating minor compliance lapses.
• The Company's net losses for the fiscal years ended December 31, 2022, 2023, and 2024 were $(5,758) thousand, $(5,194) thousand, and $(5,299) thousand, respectively, indicating ongoing unprofitability.
• Total Shareholder Return (TSR) was negative for 2022 and 2023, at $(61.16) and $(19.57) respectively, although it was positive at $4.35 for 2024.

Risks

• Shareholder Activism and Litigation Risk: The ongoing dispute with Jeffrey Feinglas regarding his director nominations poses a risk of litigation, which could incur further legal costs and potentially disrupt the Annual Meeting.
• Reputational Risk: The public dispute with a shareholder could negatively impact the company's reputation and investor confidence.
• Operational Disruption: If litigation forces a delay of the Annual Meeting, it could disrupt corporate governance processes and decision-making.
• Broker Non-Votes: If Mr. Feinglas provides proxy materials, none of the matters to be considered at the Annual Meeting will be considered routine under Broker Rules, meaning brokers cannot vote shares without instructions on Proposals 1, 2, and 3, potentially impacting quorum or vote outcomes.
• Cybersecurity Risk: The Audit Committee's oversight of cybersecurity risks indicates this is a recognized area of concern for the company, implying potential exposure to cyber threats.

Future Outlook

The document primarily focuses on the upcoming annual meeting and corporate governance matters. It mentions the company's goals of 'proving commercial viability of our products, generating interest from end users and original equipment manufacturers and licensing our technology' as reasons for the expertise of certain directors, implying a strategic focus on commercialization and market penetration.

Management Comments

• "You are invited to attend the 2025 annual meeting of stockholders... The Annual Meeting will be completely virtual conducted live via the Internet." Colin James Deller, Chief Executive Officer.
• "Your vote will be especially important this year." Company statement regarding the contested director nomination.
• "WE URGE YOU TO VOTE ONLY ON THE WHITE PROXY CARD FOR THE BOARDS PROPOSED DIRECTOR NOMINEES, TO DISREGARD ANY MATERIALS SENT TO YOU BY, OR ON BEHALF OF, MR. FEINGLAS, AND TO NOT SIGN, RETURN OR VOTE ANY PROXY CARD SENT TO YOU BY, OR ON BEHALF OF, MR. FEINGLAS." Company statement regarding the Feinglas nomination.
• "We are not responsible for the accuracy of any information provided by or relating to Mr. Feinglas or the Purported Feinglas Nominees contained in any proxy solicitation materials filed or disseminated by, or on behalf of, Mr. Feinglas or any other statements that Mr. Feinglas or his respective representatives have made or may otherwise make." Company statement regarding the Feinglas nomination.
• "The Board recommends that you vote FOR the Boards proposed director nominees Judith S. Schrecker, Catharine M. de Lacy, G. Todd Silva, Colin James Deller, Anthony DiGiandomenico and Louis J. Basenese." Board recommendation.
• "The compensation actually paid to our PEO and the average amount of compensation actually paid to our non-PEO NEO during the periods presented are not directly correlated with TSR. We do utilize several performance measures to align executive compensation with our performance, but those tend not to be financial performance measures, such as TSR." Compensation Discussion.

Industry Context

The document highlights the company's business in combustion, technology, air pollution control, and air emission regulation, indicating its position in environmental technology and industrial sectors. The appointment of directors with experience in upstream, midstream, and downstream oil and gas, and energy, suggests a strategic alignment with these industries for product application. The inclusion of 'impact investing and environmental, social and governance investing, reporting and/or compliance' as desired director qualifications indicates an awareness of current investment trends and regulatory focus within its industry.

Comparison to Industry Standards

• The Compensation Committee states it gathers and reviews data from the National Association of Corporate Directors and various publicly traded companies believed to be similar in market capitalization, number of employees, revenue, net cash, and industries (combustion, technology, air pollution control, intellectual property, start-up companies, research and development, strategic planning, business development, upstream, midstream and downstream oil and gas, energy, finance, accounting and banking, impact investing, ESG) to establish director compensation, indicating an attempt to benchmark against industry peers.
• The company's consistent net losses for 2022, 2023, and 2024, and negative Total Shareholder Return (TSR) for 2022 and 2023, suggest underperformance relative to a healthy, growing company, though direct industry comparisons of financial results are not provided in the document.
• The company's statement that 'compensation actually paid... are not directly correlated with TSR' and that they 'utilize several performance measures to align executive compensation with our performance, but those tend not to be financial performance measures, such as TSR' suggests a compensation philosophy that might deviate from typical market practices that heavily link executive pay to shareholder returns.

Management Changes

Corporate Governance

Legal Proceedings

• Jeffrey Feinglas submitted a notice to nominate two director candidates, which the Company has informed him is invalid due to failure to comply with Bylaws and material omissions/deficiencies.
• The Company states that any director nominations by Mr. Feinglas will be disregarded, and no proxies voted for his nominees will be recognized or tabulated at the Annual Meeting, unless otherwise determined by a court.
• The Company explicitly states there is currently no litigation pending related to the Purported Feinglas Notice or any circumstances related to it. However, it acknowledges that if litigation occurs and a court deems the notice valid, the Company would amend its proxy statement and potentially delay the Annual Meeting.

Related Party Transactions

• **Investments by clirSPV LLC**: In connection with a private placement in July 2018, clirSPV LLC was granted a Participation Right to purchase new equity securities to maintain a 19.99% ownership, which expired on December 31, 2024. In June 2024, clirSPV LLC subscribed for 3,350,000 shares of common stock, Pre-Funded Warrants for up to 1,343,000 shares, and Private Warrants for up to 7,039,500 shares, for aggregate gross proceeds of approximately $4.3 million. The SPV Purchase Agreement and related Voting Agreement terminated effective February 19, 2025, as SPV's beneficial ownership declined to less than 10%.
• **DiGiandomenico Cooperation Agreement**: On May 22, 2025, the Company entered into a Cooperation Agreement with Anthony DiGiandomenico, leading to the irrevocable withdrawal of his previous director nomination attempt. The Company agreed to increase the Board size and appoint Messrs. DiGiandomenico and Louis J. Basenese to the Board, and nominate them for election. The DiGiandomenico Parties agreed to vote their shares in accordance with the Board's recommendations on most proposals and agreed to certain standstill provisions (e.g., not soliciting proxies, not acquiring more than 3.5% beneficial ownership). The Company agreed to pay Mr. DiGiandomenico up to $20,000 for fees and expenses.
• **Clarkson Cooperation Agreement**: On May 22, 2025, the Company entered into a Cooperation Agreement with Richard D. Clarkson, leading to the irrevocable withdrawal of his previous director nomination attempts. This agreement also contributed to the appointment of Messrs. DiGiandomenico and Louis J. Basenese to the Board and their nomination for election. The Clarkson Parties agreed to vote their shares in accordance with the Board's recommendations on most proposals and agreed to certain standstill provisions (e.g., not soliciting proxies, not acquiring more than 3.5% beneficial ownership). The Company agreed to pay Mr. Clarkson up to $2,000 for fees and expenses.

Stakeholder Impact

• **Shareholders**: Directly impacted by voting decisions for directors, auditor, and executive compensation. The ongoing shareholder dispute with Mr. Feinglas and the Board's strong recommendation to vote only on the WHITE proxy card indicate a potential division among shareholders or an attempt to consolidate voting power. The termination of the SPV's voting agreement and participation right could alter the influence of a significant shareholder.
• **Management/Executives**: Executive compensation and bonus structures are detailed, with changes effective January 1, 2025, impacting their remuneration. The clawback policy adds a layer of accountability.
• **Board of Directors**: Changes in board composition (Mr. Maley not standing for re-election, appointment of Messrs. DiGiandomenico and Basenese) and size (reducing to six members) will affect board dynamics and oversight.
• **Employees**: General employee benefit programs are mentioned, and the corporate incentive program aims to attract, retain, and reward employees, contributing to employee morale and retention.

Next Steps

• Stockholders are to vote on director elections, auditor appointment, and executive compensation at the virtual Annual Meeting on July 25, 2025.
• The Board will be comprised of six members after the Annual Meeting, following Mr. Maley's decision not to stand for re-election and the Board's decision to decrease its size.
• The Audit Committee will reconsider retaining BPM CPA LLP if stockholders do not approve their selection.
• The Board and Compensation Committee will consider the outcome of the advisory vote on executive compensation when making future compensation decisions.
• Stockholder proposals for the 2026 Annual Meeting must be received by February 13, 2026 (for inclusion in proxy statement under Rule 14a-8) or between March 27, 2026, and April 26, 2026 (under Bylaws for direct nomination/proposal).

Key Dates

Recommendation

Keywords

SEC filing, proxy statement, annual meeting, corporate governance, director election, executive compensation, shareholder dispute, ClearSign Technologies Corporation, CLIR, independent auditor, risk management, stock compensation, equity awards, related party transactions, Nasdaq listing rules, environmental technology, combustion, air pollution control